Focusing specifically on tumors, these OnB have demonstrated efficacy in reversing hypoxic conditions, leading to a subsequent reduction in the expression of HiF-1α across various tumor types and cancer cell lines (Table 1). The gene discussed is HIF1A; the disease is cancer.